English | Español
Amanda Rupp | Oct 3, 2016

FDA outlines risks of homeopathic teething gels, tablets
John Breslin | Oct 3, 2016

Millions claiming health insurance credits fail to file correct tax forms, choose not to file at all
Amanda Rupp | Oct 3, 2016

Amgen to present new data concerning melanoma, metastatic colorectal cancer treatments
Amanda Rupp | Oct 2, 2016

FDA approves Ilaris expansion for three rare diseases
Amanda Rupp | Oct 2, 2016

Boehringer Ingelheim partners with ViraTherapeutics for immuno-oncology project
Amanda Rupp | Oct 2, 2016

Mental Illness Awareness Week honors bipolar, depression publications
Amanda Rupp | Oct 2, 2016

Parkinson’s researcher turned patient shares information 'for greater good'
Amanda Rupp | Oct 2, 2016

NORD, 300 other organizations gather on Capitol Hill for medical research rally

Trending
+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'